Fat and Bone Marrow Based Point of Care Injections Now: When/Why/Where?

Description

In this talk, Dr. Ansar Mahmood shares his journey into the world of orthobiologics and the use of Platelet-Rich Plasma (PRP) in clinical practice. He starts by summarizing the evolution of PRP treatments over 15 years, reflecting on how it was initially seen as a sophisticated and expensive procedure requiring special equipment, training, and understanding of growth factors. Dr. Mahmood emphasizes the necessity of understanding the different methodologies and formulations of PRP available today, noting that despite a growing body of randomized controlled trials (RCTs) indicating PRP's efficacy, consistency across studies is hampered by the heterogeneity of PRP products. He highlights the importance of proper governance, recording detailed patient data, and following treatment protocols to ensure successful outcomes. The talk also touches upon the challenges in the UK healthcare system regarding innovation in treatment methodologies, discussing the potential of alternative therapies like adipose-derived cells and the need for rigorous data collection to substantiate their benefits. Throughout the presentation, Dr. Mahmood encourages a critical approach to emerging therapies, calling for further research and careful consideration of patient safety.

DOI: 10.1302/3114-221767

Specialties